Control of Blood Pressure and Risk Attenuation-rural Bangladesh, Pakistan, Sri Lanka, Feasibility Study

NCT02341651 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 453

Last updated 2025-02-06

No results posted yet for this study

Summary

High blood pressure (BP) is the leading attributable risk for cardiovascular disease (CVD). In rural South Asia, hypertension remains to be a significant public health issue with sub-optimal rates of case finding and management. A trial to investigate integrated primary care strategies to control hypertension is planned. Packaged interventions for the planned full-scale study are varying combinations of 1) home health education (HHE) by trained community health workers (CHW), 2) trained government primary health centre mid-level providers (MLP) led care and 3) trained private practitioners. The goal of the full-scale study is to test which combination of the above interventions is the most effective in lowering blood pressure among adults with hypertension in rural communities. In addition, the full-scale study aims to quantify the incremental cost- effectiveness of each approach in terms of cost per projected cardiovascular disease (CVD) disability adjusted life-years (DALYs) averted.

Conditions

Interventions

OTHER

Multicomponent intervention

Multicomponent intervention is a combination of the following 1) community health worker (CHW)- led blood pressure (BP) screening and referral to provider, plus 2) home health education (HHE) adapted to the local diet by trained CHW plus 3) trained primary health center mid-level providers (MLP) and physicians using evidence-based treatment algorithm of BP lowering in all and lipid lowering for high risk, plus 4) process-based incentives

Sponsors & Collaborators

  • International Centre for Diarrhoeal Disease Research, Bangladesh

    collaborator OTHER
  • Aga Khan University

    collaborator OTHER
  • University of Kelaniya

    collaborator OTHER
  • Duke-NUS Graduate Medical School

    lead OTHER

Principal Investigators

  • Tazeen H Jafar, MD, MPH · Duke-NUS, Singapore

  • Aliya Naheed · Initiative for Non-Communicable Diseases icddr,b, Bangladesh

  • Imtiaz Jehan · Aga Khan University

  • Asita de Silva · University of Kelaniya, Sri Lanka

  • Shah Ebrahim · London School of Hygiene and Tropical Medicine

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • Bangladesh
  • Pakistan
  • Sri Lanka

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02341651 on ClinicalTrials.gov